Literature DB >> 17174554

Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase.

Zhi-Yi Cheng1, Wen-Jie Li, Feng He, Jun-Min Zhou, Xiao-Feng Zhu.   

Abstract

4-Aryl-5-cyano-2H-1,2,3-triazoles bearing a variety of substituting groups on 4-phenyl were synthesized. The chemicals, designed as HER2 tyrosine kinase inhibitors, were screened for bioactivity of inhibiting growth of breast cancer MDA-MB-453 cells. The lowest IC(50) value of inhibiting HER2 tyrosine kinase phosphorylation in breast cancer cells is 6.6microM and the IC(50) value of cell growth inhibition is correspondingly 30.9microM. The lipophilicity of substituting groups on triazoles is the main factor to influence their bioactivities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174554     DOI: 10.1016/j.bmc.2006.09.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells.

Authors:  Jaclyn S Long; Yuko Fujiwara; Joanne Edwards; Claire L Tannahill; Gabor Tigyi; Susan Pyne; Nigel J Pyne
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

2.  Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Ute F Röhrig; Somi Reddy Majjigapu; Pierre Vogel; Aline Reynaud; Florence Pojer; Nahzli Dilek; Patrick Reichenbach; Kelly Ascenção; Melita Irving; George Coukos; Olivier Michielin; Vincent Zoete
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

3.  Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.

Authors:  Stanislav A Bakunov; Svetlana M Bakunova; Tanja Wenzler; Maedot Ghebru; Karl A Werbovetz; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

4.  Neglected disease - african sleeping sickness: recent synthetic and modeling advances.

Authors:  Sarvesh K Paliwal; Ankita Narayan Verma; Shailendra Paliwal
Journal:  Sci Pharm       Date:  2011-05-10

5.  Identifying HER2 inhibitors from natural products database.

Authors:  Shun-Chieh Yang; Su-Sen Chang; Calvin Yu-Chian Chen
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

6.  Synthesis, characterization, monolayer assembly and 2D lanthanide coordination of a linear terphenyl-di(propiolonitrile) linker on Ag(111).

Authors:  Zhi Chen; Svetlana Klyatskaya; José I Urgel; David Écija; Olaf Fuhr; Willi Auwärter; Johannes V Barth; Mario Ruben
Journal:  Beilstein J Nanotechnol       Date:  2015-01-29       Impact factor: 3.649

Review 7.  The application of click chemistry in the synthesis of agents with anticancer activity.

Authors:  Nan Ma; Ying Wang; Bing-Xin Zhao; Wen-Cai Ye; Sheng Jiang
Journal:  Drug Des Devel Ther       Date:  2015-03-12       Impact factor: 4.162

Review 8.  Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties.

Authors:  Ihsan Ullah; Muhammad Ilyas; Muhammad Omer; Muhammad Alamzeb; Muhammad Sohail
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

9.  New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2.

Authors:  Israa A Seliem; Adel S Girgis; Yassmin Moatasim; Ahmed Kandeil; Ahmed Mostafa; Mohamed A Ali; Mohamed S Bekheit; Siva S Panda
Journal:  ChemMedChem       Date:  2021-09-06       Impact factor: 3.540

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.